ARS Pharmaceuticals, Inc. (SPRY)
2.92
-0.44
(-13.10%)
USD |
NASDAQ |
Nov 20, 15:35
ARS Pharmaceuticals 30-Day Average Daily Volume : 2.199M for Nov. 19, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| November 19, 2026 | 2.199M |
| November 18, 2026 | 2.131M |
| November 17, 2026 | 2.117M |
| November 16, 2026 | 2.118M |
| November 13, 2026 | 2.063M |
| November 12, 2026 | 2.081M |
| November 11, 2026 | 2.070M |
| November 10, 2026 | 1.985M |
| November 09, 2026 | 1.931M |
| November 06, 2026 | 1.856M |
| November 05, 2026 | 1.702M |
| November 04, 2026 | 1.644M |
| November 03, 2026 | 1.607M |
| November 02, 2026 | 1.568M |
| October 30, 2026 | 1.537M |
| October 29, 2026 | 1.542M |
| October 28, 2026 | 1.536M |
| October 27, 2026 | 1.500M |
| October 26, 2026 | 1.538M |
| October 23, 2026 | 1.562M |
| October 22, 2026 | 1.597M |
| October 21, 2026 | 1.574M |
| October 20, 2026 | 1.569M |
| October 19, 2026 | 1.554M |
| October 16, 2026 | 1.532M |
| Date | Value |
|---|---|
| October 15, 2026 | 1.491M |
| October 14, 2026 | 1.457M |
| October 13, 2026 | 1.444M |
| October 12, 2026 | 1.459M |
| October 09, 2026 | 1.456M |
| October 08, 2026 | 1.454M |
| October 07, 2026 | 1.440M |
| October 06, 2026 | 1.454M |
| October 05, 2026 | 1.478M |
| October 02, 2026 | 1.466M |
| October 01, 2026 | 1.475M |
| September 30, 2026 | 1.450M |
| September 29, 2026 | 1.472M |
| September 28, 2026 | 1.513M |
| September 25, 2026 | 1.649M |
| September 24, 2026 | 1.681M |
| September 23, 2026 | 1.689M |
| September 22, 2026 | 1.689M |
| September 21, 2026 | 1.691M |
| September 18, 2026 | 1.723M |
| September 17, 2026 | 1.702M |
| September 16, 2026 | 1.724M |
| September 15, 2026 | 1.740M |
| September 14, 2026 | 1.719M |
| September 11, 2026 | 1.716M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Capricor Therapeutics, Inc. | 3.939M |
| Sionna Therapeutics, Inc. | 867748.9 |
| Ardelyx, Inc. | 4.635M |
| Zentalis Pharmaceuticals, Inc. | 1.354M |
| Compass Therapeutics, Inc. | 2.401M |